Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
The Best 10 Innovation Developments of the Year - 2Schools to start reopening after Nigeria mass abduction
- 3What's going around right now? COVID, flu, stomach bug on the rise
- 4Instructions to Keep up with Your Traded Teeth for Life span
- 5Investigating Inside Plan and Home Style: Change Your Residing Space
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- Steinmeier honours Italian 'guest workers' who rebuilt German economy
- Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
- Strength training is crucial after menopause. How to make the most of your workouts
- Telecommute Arrangement: What's Pivotal for Your Efficiency?
- The Extraordinary Excursion of Dental Embed Innovation
- ‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- The World's Dazzling Regular Miracles
- 7 Well known Vacation spots In The US
